4 assets in Choledocholithiasis

Therapeutic assets addressing Choledocholithiasis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Midazolam Choledocholithiasis	National University of Malaysia	P4	BBB (73)
Meperidine Choledocholithiasis	National University of Malaysia	P4	BBB (72)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Choledocholithiasis	National University of Malaysia	P2	B (57)
Gentamicin Choledocholithiasis	National University of Malaysia	P2	CCC (53)